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INTRODUCTION

Microcytic erythrocytosis is an abnormal
CBC (complete blood count) finding that
is under-recognized, poorly understood,
and consequently under-utilized in
patient care. It is characterized by
decreased MCV and increased RBC
count. Its etiology is likely multifactorial
and includes thalassemias and
hemoglobinopathies. The focus of our
study was to determine the relative
prevalence of hemoglobin-associated
disorders in patients revealing microcytic
erythrocytosis on CBC and to
demonstrate whether or not hemoglobin
variant analysis should be included in the
diagnostic work-up of such cases.
METHODS

Data from all CBCs within a 2 year period at
Jefferson were reviewed, and patients
meeting the inclusion criteria of microcytosis
(MCV <80 fL) and erythrocytosis (RBC count
≥5.2x106 T/L (Female) and >6x106 T/L
(Male)) were selected. The sample size was
137 patients with 87 females and 50 males;
ages ranged from: 1-91 years with median
age of 46 years. The racial distribution
comprised of 49 Caucasians, 44 African
Americans, 24 Asians and 20 unspecified.
Hemoglobin values for the patients ranged
from 7.2– 16.1 g/dL, MCVs ranged from
54.5-79 fL and RBC count ranged from 5.27.5x 106 T/L. 74 patients had mild anemia
while 63 patients had hemoglobin levels
within the gender-specified reference range.
The results of hemoglobin variant analysis
performed by high-performance liquid
chromatography on these patients were
reviewed.
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Hemoglobin Variant Analysis Pattern Consistent
With
Beta-thalassemia trait
Delta/beta-thalassemia trait
Hemoglobin E disease
Hereditary persistence of fetal hemoglobin (HPFH)
Possible HPFH
Beta-thalassemia with HPFH
Delta/beta-thalassemia with iron deficiency anemia
Hemoglobin C trait with beta-thalassemia
Hemoglobin C trait with possible alpha-thalassemia
Hemoglobin C with HPFH
Unidentified hemoglobinopathy with possible
delta/beta-thalassemia
Hemoglobin S trait combined with beta and
possible alpha-thalassemia
Hemoglobin S trait with beta-thalassemia
Normal pattern
Total # of patients

Number of
Patients
70
1
4
1
4
2
1
1
2
1

Percentage
of Patients
51.1
0.7
2.9
0.7
2.9
1.5
0.7
0.7
1.5
0.7

2

1.5

3

2.2

1
44*
137

0.7
32.1
100

Table 1: Relative prevalence of hemoglobin-associated conditions in patients revealing microcytic
erythrocytosis on CBC.

• 93 of the 137 (67.9%) had a thalassemia trait and/or a
hemoglobinopathy. Amongst these, beta-thalassemia trait topped
the list, followed by hemoglobin E disease, possible HPFH,HPFH
and delta-beta-thalassemia.
• The diagnosis of possible HPFH was entertained based on mild
elevation of hemoglobin F (2.3% to 3.1%) by HPLC. Since HPFH is
typically associated with normal MCV or RBC count, the microcytic
erythrocytosis noted in these patients likely represent an associated
undiscovered alpha-thalassemia trait.
• Majority, if not all, of the 44 cases with normal hemoglobin variance
analysis pattern also represent patients with possible α-thalassemia
trait, Microcytic erythrocytosis is uncommon in normal patients and
alpha thalassemia is a diagnosis of exclusion (requires DNA
analysis studies not performed here)
• Compound heterozygous conditions for either hemoglobinopathies
and/or thalassemia(s) comprised 12 cases. Unspecified abnormal
hemoglobins detected by the HPLC method remain unidentified as
no additional analyses had been performed in both cases.
• The diagnosis of delta/beta-thalassemia and concomitant iron
deficiency anemia made in 1 patient was supported by the
laboratory findings of increased hemoglobin F, decreased
hemoglobin A2 and decreased serum ferritin.
• With all these potential considerations, over 96% of the studied
cases of microcytic erythrocytosis may be categorized as having a
possible thalassemia trait and/or a hemoglobinopathy.
CONCLUSION

A

B

Figure 1A) HPLC results of a patient with beta thalassemia trait B) HPLC results of a patient with
Hemoglobin E disease

The answer to the question our study title proposed i.e. “Is
Hemoglobin Variant Analysis Helpful in the Diagnostic Work-up of
Patients Revealing Microcytic Erythrocytosis on Complete Blood
Count?” is unequivocally “yes”. Based on the observed extremely
high positive yield of hemoglobin variant analysis in determining
the etiology of erythrocytosis, we recommend that the abnormality
of microcytic erythrocytosis should automatically be flagged and
such specimens should be reflexively processed for hemoglobin
variant analysis for each previously undiagnosed patient.

